Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit. Biomed. Res. Ther. [Internet]. 2024 Apr. 30 [cited 2024 Nov. 15];11(4):6305-2. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/877